Companion research to support your life-science innovation development efforts to save every patient.

Because we believe in “Patient Innovation First. 


Infectious Disease | Ultra-Rare, Rare & Orphan Disease

Oncology Medicine | Real-World Evidence

Virtual Clinical Trials | Innovation Development

Digital Health Solutions | Advisory & Consulting

Disease & Cancer Genetics

Research and Development

Virtual trial Design / Real-World Evidence

Post Market Surveillance


Advisory & Consulting




Innovation Along the Patient Journey Continuum

Our mission is to ensure that therapeutics and vaccines developed within the life science industry factor in every patient ethnicity and demographics to bolster product efficacy, health equity, and effective patient outcomes.

At Rubix LS, we understand that practical therapeutic innovation doesn’t just happen within the lab; it occurs throughout the entire patient journey.  Enabling better and diverse health outcomes starts by designing your early-stage development focus that encompasses various data sets.

Also supporting the federal missions.

Our Innovations.

We create the products that we’d like to see in the world today.  We’re working with multiple organizations to create access and potential therapeutic opportunities to ensure that novel innovations can be accessed for everyone.

Latest News & Articles

Rubix LS on Pharma Tech Outlook

Rubix LS on Pharma Tech Outlook

Recently our Founder and CEO, Reginald Swift, sat down with the team at Pharma Tech Outlook magazine to discuss the changes happening with the pharma industry and how digital health, particularly virtual clinical trials are mobilizing access of pipeline therapeutics...

read more
Rubix LS Is Supporting The Federal COVID-19 Response.

Rubix LS Is Supporting The Federal COVID-19 Response.

Rubix LS has joined the federal consortium of industry partners to fully develop plans and strategies for mobilizing robust response measures toward the growing COVID-19 worldwide pandemic in the United States. Rubix LS is joined by countless other firms, within the...

read more